Dermatomyositis and polymyositis (myositis): vizsgálatok itt: Ausztrália
9 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of AZD0120 in Autoimmune Diseases
- Where
- Clayton, Darlinghurst, Waratah
- Életkor
- 18 év to 75 év
- People
- 27 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07295847 - 3. fázisNot yet taking people in AusztráliaA Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
- Where
- Campbelltown, Ivanhoe, Nedlands, Wollongong
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07789015 · EU 2026-526365-24-00 - 1/2. fázisTaking peopleA Study to Test CRT-402 in Refractory Autoimmune Disease
- Where
- Nedlands
- Életkor
- 18 év and over
- People
- 34
- Run by
- Myeloid Therapeutics
See details and how to joinNCT07778446 - 1. fázisCsak meghívásosA Study of KITE-363 in Participants With Refractory Autoimmune Diseases
- Where
- Fitzroy, Syndey
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07038447 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Where
- Camperdown, Nedlands, New Lambton, Southport, Woodville South
- Életkor
- 18 év to 75 év
- People
- 240 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06455449 - 1. fázisTaking peopleA Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases
- Where
- Melbourne
- Életkor
- 18 év to 75 év
- People
- 60
- Run by
- Xencor, Inc.
See details and how to joinNCT07284797 - 1. fázisTaking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Camperdown, Melbourne, Sydney
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - 1. fázisCsak meghívásosPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Camperdown, Melbourne, Sydney
- Életkor
- 18 év to 85 év
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - 1. fázisTaking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Brisbane, Camperdown, Clayton
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00